Latest filing published 14 Jun 2022 for NanoVibronix, Inc., €2,199.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
This profile gathers the share dealings of Stephen Russell Brown across 4 companies, led by IDT Corp, ENvue Medical, Inc. and RxBids. The record holds 19 filings, for trades running from 3 January 2006 to 14 June 2022.
Market trades split into 2 purchases (€2,199) and 3 sales (€1.3M). The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 13 share grants and 1 option exercise. Since January 2022: 1 purchase and no sales on the market.
The record was last updated on 14 June 2022 with an open-market purchase (€2,199) in ENvue Medical, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration